WASHINGTON - Hopes have been raised of a new treatment to free thousands of diabetes sufferers from the burden of daily needle injections.
WASHINGTON - A gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body’s insulin-producing cells has been identified by scientists at Stanford University.
WASHINGTON - Insufficient sleep may contribute to the development of insulin resistance and reduced glucose tolerance, which in turn may increase the long-term risk of diabetes, concludes a new study.
WASHINGTON - Scientists are working on a new technology to analyze large numbers of novel marine microbes, which could lead to more efficient and greener ways to manufacture new drugs for conditions such as epilepsy, diabetes, flu and other viruses.
WASHINGTON - Computational biologists at Carnegie Mellon University have developed a new analytical technique to detect the genetic causes behind complex disease syndromes like diabetes, asthma and cancer, which are characterized by multiple clinical and molecular traits.
WASHINGTON - Experimenting on mice, a research team has found a way to convert another type of pancreas cell into the critical insulin-producing beta cells, which are lost in type I diabetes patients.
Husband says mother in NY crash wasn’t a drinker
GARDEN CITY, N.Y. — The husband of a suburban New York mother who caused a car crash that killed her and seven others said Thursday she didn’t have a drinking problem and suggested diabetes and other health problems were to blame.
Denmark’s Novo Nordisk posts rise in 2Q profits
COPENHAGEN — Danish drug maker Novo Nordisk A/S on Thursday said second-quarter net profit rose by 21 percent, aided by a surge in insulin sales in North America.
WASHINGTON - Scientists have found that non-invasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes.